BD Holding, Inc.

Coralville, IA

UEI
C8DQNL9C97V8
CAGE
5GL32
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
BioVentures Center, 2500 Crosspark Rd w245, Coralville, IA 52241, USA
Website
bdmethylation.com
Founded
2009
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About BD Holding, Inc.

BD Holding, Inc. is a corporate entity registered in the System for Award Management (SAM.gov) since May 16, 2009, with its primary location in Coralville, Iowa. The company is structured as a for-profit, Subchapter S Corporation focused on biomedical and epigenetic research. While specific details about the company's broader mission are not provided, its federal grant award history suggests a strong emphasis on advanced scientific research involving genetic and molecular analysis across various health domains.

The company has received multiple federal grants from prestigious agencies including the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Cancer Institute, and National Institute on Aging. These grants primarily support innovative epigenetic research projects, such as developing an Alcohol T Score to quantify alcohol consumption's impact on coronary heart disease, creating a saliva-based epigenetic assay for assessing vitamin B9 and B12 status, and designing DNA methylation tests to improve lung cancer screening protocols. Each project demonstrates sophisticated molecular diagnostic capabilities, utilizing advanced techniques like machine learning, methylation-sensitive digital PCR, and genetic-epigenetic signature analysis. The research aims to enhance precision medicine by developing novel diagnostic tools that can objectively assess health risks, predict disease progression, and potentially guide more personalized medical interventions across areas including cardiovascular health, cancer screening, and nutritional assessment.

Quick answers

What is BD Holding, Inc.'s UEI?

BD Holding, Inc.'s Unique Entity ID (UEI) in SAM.gov is C8DQNL9C97V8.

What is BD Holding, Inc.'s CAGE code?

BD Holding, Inc.'s CAGE code is 5GL32.

Where is BD Holding, Inc. located?

BD Holding, Inc.'s physical address in SAM.gov is BioVentures Center, 2500 Crosspark Rd w245, Coralville, IA 52241, USA.

Is BD Holding, Inc. registered in SAM.gov?

Yes. BD Holding, Inc.'s SAM.gov registration is active through March 30, 2027.

What is BD Holding, Inc.'s most recent federal award?

BD Holding, Inc.'s most recent federal grant award is A test for heavy alcohol consumption in first episode coronary heart disease - excessive alcohol consumption (EAC) is… (R43AA032450), from National Institute on Alcohol Abuse and Alcoholism, on August 15, 2025.

On GovTribe

See BD Holding, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors